Monitoring the Session

SB 1867

Perry’s bill adding THC variants to Penalty Group 2

Died in committee

Verdict: No flags

No flagsInitial review
Sen. Charles PerryRSenate 28

Initial review · graded Oct 20, 2026 · Headline, summary and grade are analysis of the bill text, not a finding about any person · How we grade

Caption

relating to the addition of certain substances to Penalty Group 2 of the Texas Controlled Substances Act.

Caption from analyzed text · version I.

Summary

Delta-8, delta-10, HHC and friends become controlled substances.

The bill adds a long list of THC variants to Penalty Group 2 of the Texas Controlled Substances Act, including delta-8, delta-10, THCP, HHC, THC-O acetate, THC metabolites, and several synthetic cannabinoids. It touches anyone who makes, sells, or holds products with these substances, which this text now treats as controlled substances in Penalty Group 2. Starting September 1, 2025, conduct involving these listed substances falls under the Penalty Group 2 offenses, and the new rules apply only to conduct on or after that date.

Labels

Labels: NEVER GOT A HEARING. Filed Mar 4, 2025 and referred to the Senate State Affairs committee. No public hearing. The bill died.

Receipt

The receipt

89R-SB1867 · 2025-03-04

SOLD BY

ITEM

relating to the addition of certain substances to Penalty Group 2 of the Texas Controlled Substances Act.

WHAT IT DOES

Delta-8, delta-10, HHC and friends become controlled substances.

The bill adds a long list of THC variants to Penalty Group 2 of the Texas Controlled Substances Act, including delta-8, delta-10, THCP, HHC, THC-O acetate, THC metabolites, and several synthetic cannabinoids. It touches anyone who makes, sells, or holds products with these substances, which this text now treats as controlled substances in Penalty Group 2. Starting September 1, 2025, conduct involving these listed substances falls under the Penalty Group 2 offenses, and the new rules apply only to conduct on or after that date.

CHARGES

[ ] NONE FOUND

TOTAL

No fiscal note in the loaded record.

HISTORY

  1. Received by the Secretary of the Senate
  2. Filed
  3. Read first time
  4. Referred to State Affairs
FILED UNDER

No verified beat found.

No flags

THANK YOU FOR CHECKING THE RECEIPT

CAMPAIGN PAID FOR BY

CAMPAIGN PAID FOR BY

Donors

Not tied to this bill.

Sources

The author's campaign account only. Own money and internal transfers are separate on the member page.

Derived itemized flow · Jul 1, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.

Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.

Texans for Lawsuit Reform PAC$60,000.00

Texans for Lawsuit Reform PAC

$60,000.00

Cash
$60,000.00
Paid by others
$0.00
Total
$60,000.00

Also funds 124 other sitting lawmakers.

Derived recipient stock · Jul 10, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.

TEC account match.

Team
Sources

Derived itemized flow · Nov 13, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.

Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.

Report IDs: 100983698, 101007598, 101030579, 101072377.

Ryan Texas PAC$35,000.00

Ryan Texas PAC

$35,000.00

Cash
$35,000.00
Paid by others
$0.00
Total
$35,000.00

Also funds 25 other sitting lawmakers.

Derived recipient stock · Sep 23, 2024 to Oct 22, 2026. State data as of Nov 4, 2026.

TEC account match.

Team
Sources

Derived itemized flow · Dec 13, 2024 to Mar 12, 2026. State data as of Nov 4, 2026.

Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.

Report IDs: 100983698, 101057700.

Fort Stockton Holdings LP$25,000.00

Fort Stockton Holdings LP

$25,000.00

Cash
$25,000.00
Paid by others
$0.00
Total
$25,000.00

Also funds 0 other sitting lawmakers.

Derived recipient stock · on Nov 23, 2024. State data as of Nov 4, 2026.

Name match, not a verified identity: normalized filed name and state.

Sources

Derived itemized flow · on Nov 23, 2024. State data as of Nov 4, 2026.

Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.

Report IDs: 100983698.

Money

Missing data does not establish zero giving. Display amounts are rounded.

×

Texans for Lawsuit Reform PAC

$60,000.00

Cash
$60,000.00
Paid by others
$0.00
Total
$60,000.00

Also funds 124 other sitting lawmakers.

Derived recipient stock · Jul 10, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.

TEC account match.

Team
Sources

Derived itemized flow · Nov 13, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.

Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.

Report IDs: 100983698, 101007598, 101030579, 101072377.

×

Ryan Texas PAC

$35,000.00

Cash
$35,000.00
Paid by others
$0.00
Total
$35,000.00

Also funds 25 other sitting lawmakers.

Derived recipient stock · Sep 23, 2024 to Oct 22, 2026. State data as of Nov 4, 2026.

TEC account match.

Team
Sources

Derived itemized flow · Dec 13, 2024 to Mar 12, 2026. State data as of Nov 4, 2026.

Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.

Report IDs: 100983698, 101057700.

×

Fort Stockton Holdings LP

$25,000.00

Cash
$25,000.00
Paid by others
$0.00
Total
$25,000.00

Also funds 0 other sitting lawmakers.

Derived recipient stock · on Nov 23, 2024. State data as of Nov 4, 2026.

Name match, not a verified identity: normalized filed name and state.

Sources

Derived itemized flow · on Nov 23, 2024. State data as of Nov 4, 2026.

Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.

Report IDs: 100983698.

Votes

No floor vote loaded for this bill.

Fiscal

No fiscal note in the loaded record.

How this was graded

Analysis of text version I by claude-opus-5-5, Oct 20, 2026, against the published rubric.

Sources

Texas Senate · Filed Mar 4, 2025

03/17/2025 S Referred to State Affairs

Texas Legislature Online · Introduced

Data snapshot Oct 26, 2026 at 4:20 AM CDT. Grades, charges, quotes and corrections follow the published record.

Senate committee · State Affairs · Final status: Died in committee

Subjects

Alcoholism & Drug Abuse

Crimes--Drugs

Text

The text as introduced · 1,473 words

89R15191 CJD-F

By: Perry
S.B. No. 1867

A BILL TO BE ENTITLED

AN ACT

relating to the addition of certain substances to Penalty Group 2 of

the Texas Controlled Substances Act.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:

SECTION 1. Section 481.103(a), Health and Safety Code, is

amended to read as follows:

(a) Penalty Group 2 consists of:

(1) any quantity of the following hallucinogenic

substances, their salts, isomers, and salts of isomers, unless

specifically excepted, if the existence of these salts, isomers,

and salts of isomers is possible within the specific chemical

designation:

5-(2-aminopropyl)benzofuran (5-APB);

6-(2-aminopropyl)benzofuran (6-APB);

5-(2-aminopropyl)-2,3-dihydrobenzofuran

(5-APDB);

6-(2-aminopropyl)-2,3-dihydrobenzofuran

(6-APDB);

5-(2-aminopropyl)indole (5-IT,5-API);

6-(2-aminopropyl)indole (6-IT,6-API);

1-(benzofuran-5-yl)-N-methylpropan-2-amine

(5-MAPB);

1-(benzofuran-6-yl)-N-methylpropan-2-amine

(6-MAPB);

Benzothiophenylcyclohexylpiperidine (BTCP);

8-bromo-alpha-methyl-benzo[1,2-b:4,5-b']difuran-

4-ethanamine (trade or other name: Bromo-DragonFLY);

Desoxypipradrol (2-benzhydrylpiperidine);

2, 5-dimethoxyamphetamine (some trade or other

names: 2, 5-dimethoxy-alpha-methylphenethylamine; 2, 5-DMA);

Diphenylprolinol (diphenyl(pyrrolidin-2-yl)

methanol, D2PM);

Dronabinol (synthetic) in sesame oil and

encapsulated in a soft gelatin capsule in a U.S. Food and Drug

Administration approved drug product (some trade or other names for

Dronabinol: (a6aR-trans)-6a,7,8,10a-tetrahydro- 6,6, 9-

trimethyl-3-pentyl-6H- dibenzo [b,d]pyran-1-ol or (-)-delta-9-

(trans)- tetrahydrocannabinol);

Ethylamine Analog of Phencyclidine (some trade or

other names: N-ethyl-1-phenylcyclohexylamine, (1-

phenylcyclohexyl) ethylamine, N-(1-phenylcyclohexyl) ethylamine,

cyclohexamine, PCE);

2-ethylamino-2-(3-methoxyphenyl)cyclohexanone

(trade or other name: methoxetamine);

Ibogaine (some trade or other names: 7-Ethyl-6,

6, beta 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5H-

pyrido [1', 2':1, 2] azepino [5, 4-b] indole; tabernanthe iboga.);

5-iodo-2-aminoindane (5-IAI);

Mescaline;

5-methoxy-3, 4-methylenedioxy amphetamine;

4-methoxyamphetamine (some trade or other

names: 4-methoxy-alpha-methylphenethylamine;

paramethoxyamphetamine; PMA);

4-methoxymethamphetamine (PMMA);

2-(2-methoxyphenyl)-2-(methylamino)cyclohexanone

(some trade and other names: 2-MeO-ketamine; methoxyketamine);

1-methyl- 4-phenyl-4-propionoxypiperidine (MPPP,

PPMP);

4-methyl-2, 5-dimethoxyamphetamine (some trade

and other names: 4-methyl-2, 5-dimethoxy-alpha-

methylphenethylamine; "DOM"; "STP");

3,4-methylenedioxy methamphetamine (MDMA, MDM);

3,4-methylenedioxy amphetamine;

3,4-methylenedioxy N-ethylamphetamine (Also

known as N-ethyl MDA);

5,6-methylenedioxy-2-aminoindane (MDAI);

Nabilone (Another name for nabilone: (+)-trans-

3-(1,1-dimethylheptyl)- 6,6a, 7,8,10,10a-hexahydro-1-hydroxy- 6,

6-dimethyl-9H-dibenzo[b,d] pyran-9-one;

N-benzylpiperazine (some trade or other

names: BZP; 1-benzylpiperazine);

N-ethyl-3-piperidyl benzilate;

N-hydroxy-3,4-methylenedioxyamphetamine (Also

known as N-hydroxy MDA);

4-methylaminorex;

N-methyl-3-piperidyl benzilate;

Parahexyl (some trade or other names: 3-Hexyl-1-

hydroxy-7, 8, 9, 10-tetrahydro-6, 6, 9-trimethyl-6H-dibenzo [b, d]

pyran; Synhexyl);

1-Phenylcyclohexylamine;

1-Piperidinocyclohexanecarbonitrile (PCC);

Pyrrolidine Analog of Phencyclidine (some trade

or other names: 1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP);

Tetrahydrocannabinols, other than marihuana, and

synthetic equivalents of the substances contained in the plant, or

in the resinous extractives of Cannabis, or synthetic substances,

derivatives, and their isomers with similar chemical structure and

pharmacological activity such as:

delta-1 cis or trans tetrahydrocannabinol,

and their optical isomers;

delta-6 cis or trans tetrahydrocannabinol,

and their optical isomers;

delta-3, 4 cis or trans

tetrahydrocannabinol, and its optical isomers; [ or ]

delta-5, cis or trans tetrahydrocannabinol,

and their optical isomers;

delta-6a, cis or trans tetrahydrocannabinol,

and their optical isomers;

delta-7, cis or trans tetrahydrocannabinol,

and their optical isomers;

delta-7a, cis or trans tetrahydrocannabinol,

and their optical isomers;

delta-8, cis or trans tetrahydrocannabinol,

and their optical isomers;

delta-9, cis or trans tetrahydrocannabinol,

and their optical isomers;

delta-10, cis or trans tetrahydrocannabinol,

and their optical isomers;

delta-10a, cis or trans

tetrahydrocannabinol, and their optical isomers;

delta-11, cis or trans tetrahydrocannabinol,

and their optical isomers;

delta-11-Hydroxy-tetrahydrocannabinol;

exo-tetrahydrocannabinol;

1-pentyl-3-(1-naphthoyl) indole (JWH-018);

1-butyl-3-(1-naphthoyl) indole (JWH-073);

1-pentyl-3-(4-methoxynaphthoyl) indole

(14-JWH-200);

1-pentyl-3-(2-methoxynaphthoyl) indole

(JWH-250);

1-pentyl-3-(4-chloronaphthoyl) indole

(JWH-398);

5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-

hydroxycyclohexyl]-phenol (CP-47,497);

(6aR,10aR)-9-(hydroxymethyl)-6,6-

dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo

[c]chromen-1-ol (HU-210);

(6a,10a)-9-(hydroxymethyl)-6,6-

dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydro-6H-benzo

[c]chromen-1-ol (HU-211);

tetrahydrocannabivarins, including delta-8

tetrahydrocannabivarin;

metabolites of tetrahydrocannabinol,

including 11-hydroxy-tetrahydrocannabinol,

3-hydroxy-tetrahydrocannabinol, and

7-hydroxy-tetrahydrocannabinol;

hexahydrocannabiphorol-o-ester;

hydrogenated forms of tetrahydrocannabinol,

including hexahydrocannabinol, hexahydrocannabiphorol, and

hexahydrocannabihexol;

hydrogenated forms of hexahydrocannabinol

(HHC), including 8-hydroxyhexahydrocannabinol and

10-hydroxyhexahydrocannabinol;

ester forms of tetrahydrocannabinol,

including delta-8 THC-O-acetate, delta-9 THC-O-acetate, and

hexahydrocannabinol-O-acetate;

tetrahydrocannabinols with alkyl chain of

four or more carbon atoms, including tetrahydrocannabiphorols

(THCP), tetrahydrocannabioctyls, tetrahydrocannabihexols (THCH),

tetrahydrocannabidiol (THC-JD), and tetrahydrocannabutols;

tetrahydrocannabinol acetate (THC-O);

tetrahydrocannabinol methyl ester;

N-(1-Amino-1-methyl-ethyl)-5-fluoropen

tyl-1-naphthalen-2-yl-1H-indole-3-carboxamide (XRL-11 &15);

N-(1-Amino-1-methyl-ethyl)-5-fluoropen

tyl-1-naphthalen-2-yl-1H-indole-3-carboxamide (UR-144);

N-(1-Amino-1-methyl-ethyl)-5-fluoropen

tyl-1-naphthalen-2-yl-1H-indole-3-carboxamide (FUB-144);

N-(1-Amino-1-methyl-ethyl)-5-fluoropen

tyl-1-naphthalen-2-yl-1H-indole-3-carboxamide (AMB-FUBINACA);

(3-[(1R,4R)-Isopropyl-2-methyl-1,3-benzo

dioxol-5-yl]-N-(2,4-dimethyl-3-methylbenzoyl)-N-methyl-1,2,3,4-

tetrahydroisoquinolin-6-amine) (THJ-220);

(3-[(1R,4R)-Isopropyl-2-methyl-1,3-benzo

dioxol-5-yl]-N-(2,4-dimethyl-3-methylbenzoyl)-N-methyl-1,2,3,4-

tetrahydroisoquinolin-6-amine) (RCS-4);

Cannabicycloheptanone; or

compounds of these structures, regardless of

numerical designation of atomic positions, since nomenclature of

these substances is not internationally standardized;

Thiophene Analog of Phencyclidine (some trade or

other names: 1-[1-(2-thienyl) cyclohexyl] piperidine; 2-Thienyl

Analog of Phencyclidine; TPCP, TCP);

1-pyrrolidine (some trade or other name: TCPy);

1-(3-trifluoromethylphenyl)piperazine (trade or

other name: TFMPP); and

3,4,5-trimethoxy amphetamine;

(2) Phenylacetone (some trade or other

names: Phenyl-2-propanone; P2P, Benzymethyl ketone, methyl benzyl

ketone);

(3) unless specifically excepted or unless listed in

another Penalty Group, a material, compound, mixture, or

preparation that contains any quantity of the following substances

having a potential for abuse associated with a depressant or

stimulant effect on the central nervous system:

Aminorex (some trade or other names: aminoxaphen;

2-amino-5-phenyl-2-oxazoline; 4,5-dihydro-5-

phenyl-2-oxazolamine);

Amphetamine, its salts, optical isomers, and

salts of optical isomers;

Cathinone (some trade or other names: 2-amino-1-

phenyl-1-propanone, alpha-aminopropiophenone, 2-

aminopropiophenone);

Etaqualone and its salts;

Etorphine Hydrochloride;

Fenethylline and its salts;

Lisdexamfetamine, including its salts, isomers,

and salts of isomers;

Mecloqualone and its salts;

Methaqualone and its salts;

Methcathinone (some trade or other names: 2-

methylamino-propiophenone; alpha-(methylamino)propriophenone;

2-(methylamino)-1-phenylpropan-1-one; alpha-N-

methylaminopropriophenone; monomethylpropion; ephedrone, N-

methylcathinone; methylcathinone; AL-464; AL-422; AL-463; and UR

1431);

N-Ethylamphetamine, its salts, optical isomers,

and salts of optical isomers; and

N,N-dimethylamphetamine (some trade or other

names: N,N,alpha-trimethylbenzeneethanamine;

N,N,alpha-trimethylphenethylamine), its salts, optical isomers,

and salts of optical isomers;

(4) any compound structurally derived from

2-aminopropanal by substitution at the 1-position with any

monocyclic or fused-polycyclic ring system, including:

(A) compounds further modified by:

(i) substitution in the ring system to any

extent (including alkyl, alkoxy, alkylenedioxy, haloalkyl, or

halide substituents), whether or not further substituted in the

ring system by other substituents;

(ii) substitution at the 3-position with an

alkyl substituent; or

(iii) substitution at the 2-amino nitrogen

atom with alkyl, benzyl, dialkyl, or methoxybenzyl groups, or

inclusion of the 2-amino nitrogen atom in a cyclic structure; and

(B) by example, compounds such as:

4-Methylmethcathinone (Also known as

Mephedrone);

3,4-Dimethylmethcathinone (Also known as

3,4-DMMC);

3-Fluoromethcathinone (Also known as 3-FMC);

4-Fluoromethcathinone (Also known as

Flephedrone);

3,4-Methylenedioxy-N-methylcathinone (Also

known as Methylone);

3,4-Methylenedioxypyrovalerone (Also known

as MDPV);

alpha-Pyrrolidinopentiophenone (Also known

as alpha-PVP);

Naphthylpyrovalerone (Also known as

Naphyrone);

alpha-Methylamino-valerophenone (Also known

as Pentedrone);

beta-Keto-N-methylbenzodioxolylpropylamine

(Also known as Butylone);

beta-Keto-N-methylbenzodioxolylpentanamine

(Also known as Pentylone);

beta-Keto-Ethylbenzodioxolylbutanamine

(Also known as Eutylone); and

3,4-methylenedioxy-N-ethylcathinone (Also

known as Ethylone);

(5) any compound structurally derived from tryptamine

(3-(2-aminoethyl)indole) or a ring-hydroxy tryptamine:

(A) by modification in any of the following ways:

(i) by substitution at the amine nitrogen

atom of the sidechain to any extent with alkyl or alkenyl groups or

by inclusion of the amine nitrogen atom of the side chain (and no

other atoms of the side chain) in a cyclic structure;

(ii) by substitution at the carbon atom

adjacent to the nitrogen atom of the side chain (alpha-position)

with an alkyl or alkenyl group;

(iii) by substitution in the 6-membered

ring to any extent with alkyl, alkoxy, haloalkyl, thioaklyl,

alkylenedioxy, or halide substituents; or

(iv) by substitution at the 2-position of

the tryptamine ring system with an alkyl substituent; and

(B) including:

(i) ethers and esters of the controlled

substances listed in this subdivision; and

(ii) by example, compounds such as:

alpha-ethyltryptamine;

alpha-methyltryptamine;

Bufotenine (some trade and other names:

3-(beta-Dimethylaminoethyl)-5-hydroxyindole;

3-(2-dimethylaminoethyl)- 5- indolol; N, N-dimethylserotonin;

5-hydroxy-N, N- dimethyltryptamine; mappine);

Diethyltryptamine (some trade and

other names: N, N-Diethyltryptamine, DET);

Dimethyltryptamine (trade or other

name: DMT);

5-methoxy-N, N-diisopropyltryptamine

(5-MeO-DiPT);

O-Acetylpsilocin (Trade or other name:

4-Aco-DMT);

Psilocin; and

Psilocybin;

(6) 2,5-Dimethoxyphenethylamine and any compound

structurally derived from 2,5-Dimethoxyphenethylamine by

substitution at the 4-position of the phenyl ring to any extent

(including alkyl, alkoxy, alkylenedioxy, haloalkyl, or halide

substituents), including, by example, compounds such as:

4-Bromo-2,5-dimethoxyphenethylamine (trade or

other name: 2C-B);

4-Chloro-2,5-dimethoxyphenethylamine (trade or

other name: 2C-C);

2,5-Dimethoxy-4-methylphenethylamine (trade or

other name: 2C-D);

4-Ethyl-2,5-dimethoxyphenethylamine (trade or

other name: 2C-E);

4-Iodo-2,5-dimethoxyphenethylamine (trade or

other name: 2C-I);

2,5-Dimethoxy-4-nitrophenethylamine (trade or

other name: 2C-N);

2,5-Dimethoxy-4-(n)-propylphenethylamine (trade

or other name: 2C-P);

4-Ethylthio-2,5-dimethoxyphenethylamine (trade

or other name: 2C-T-2);

4-Isopropylthio-2,5-dimethoxyphenethylamine

(trade or other name: 2C-T-4); and

2,5-Dimethoxy-4-(n)-propylthiophenethylamine

(trade or other name: 2C-T-7); and

(7) 2,5-Dimethoxyamphetamine and any compound

structurally derived from 2,5-Dimethoxyamphetamine by substitution

at the 4-position of the phenyl ring to any extent (including alkyl,

alkoxy, alkylenedioxy, haloalkyl, or halide substituents),

including, by example, compounds such as:

4-Ethylthio-2,5-dimethoxyamphetamine (trade or

other name: Aleph-2);

4-Isopropylthio-2,5-dimethoxyamphetamine (trade

or other name: Aleph-4);

4-Bromo-2,5-dimethoxyamphetamine (trade or other

name: DOB);

4-Chloro-2,5-dimethoxyamphetamine (trade or

other name: DOC);

2,5-Dimethoxy-4-ethylamphetamine (trade or other

name: DOET);

4-Iodo-2,5-dimethoxyamphetamine (trade or other

name: DOI);

2,5-Dimethoxy-4-methylamphetamine (trade or

other name: DOM);

2,5-Dimethoxy-4-nitroamphetamine (trade or other

name: DON);

4-Isopropyl-2,5-dimethoxyamphetamine (trade or

other name: DOIP); and

2,5-Dimethoxy-4-(n)-propylamphetamine (trade or

other name: DOPR).

SECTION 2. The change in law made by this Act applies only

to an offense committed on or after the effective date of this

Act. An offense committed before the effective date of this Act is

governed by the law in effect on the date the offense was committed,

and the former law is continued in effect for that purpose. For

purposes of this section, an offense was committed before the

effective date of this Act if any element of the offense occurred

before that date.

SECTION 3. This Act takes effect September 1, 2025.